Personalized vaccines: the emerging field of vaccinomics (Q57157844)

Europe PubMed Central

title

Personalized vaccines: the emerging field of vaccinomics (English)

0 references

1

Gregory A Poland

0 references

Inna G Ovsyannikova

series ordinal

2

object named as

Inna G Ovsyannikova

0 references

Robert M. Jacobson

1 reference

ORCID Public Data File 2021

author name string

Robert M Jacobson

series ordinal

3

0 references

language of work or name

English

0 references

publication date

November 2008

0 references

published in

Expert Opinion on Biological Therapy

0 references

volume

8

0 references

issue

11

0 references

page(s)

1659-67

0 references

cites work

Response to immunization with Haemophilus influenzae type b polysaccharide-pertussis vaccine and risk of Haemophilus meningitis in children with the Km(1) immunoglobulin allotype.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

The genetic basis for variation in antibody response to vaccines

21 January 2018

2 references

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

21 January 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2831634

Variability in immune response to pathogens: using measles vaccine to probe immunogenetic determinants of response

2 November 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Immunogenicity of peptides of measles virus origin and influence of adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

The HLA system. First of two parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

The HLA system. Second of two parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Polymorphism in clinical immunology - From HLA typing to immunogenetic profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Genetic susceptibility to infectious diseases: big is beautiful, but will bigger be even better?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Response to hepatitis B vaccine: multiple HLA genes are involved

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Identification of an association between HLA class II alleles and low antibody levels after measles immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Class II HLA alleles and hepatitis B virus persistence in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Human Leukocyte Antigen Class II Alleles and Rubella‐Specific Humoral and Cell‐Mediated Immunity following Measles‐Mumps‐Rubella–II Vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

HLA supertypes and immune responses to measles-mumps-rubella viral vaccine: findings and implications for vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Identification of class II HLA-DRB1*03-bound measles virus peptides by 2D-liquid chromatography tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Identification and characterization of novel, naturally processed measles virus class II HLA-DRB1 peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Hemagglutinin protein is a primary target of the measles virus-specific HLA-A2-restricted CD8+ T cell response during measles and after vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Epitope-based vaccines: an update on epitope identification, vaccine design and delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Mass spectrometry and peptide-based vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Ab and T cell epitopes of influenza A virus, knowledge and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Variation in HLA class I antigen-processing genes and susceptibility to human papillomavirus type 16-associated cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Interleukin-10 gene (IL10) polymorphisms and human papillomavirus clearance among immunosuppressed adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Genetic epidemiology of single-nucleotide polymorphisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Implications of the Human Genome Project for medical science.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Cytokine gene polymorphisms in multifactorial diseases: gateways to novel targets for immunotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Revaccination of healthy nonresponders with hepatitis B vaccine and prediction of seroprotection response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Peptide-specific CTL induction in HBV-seropositive PBMC by stimulation with peptides in vitro: novel epitopes identified from chronic carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Balanced polymorphism selected by genetic versus infectious human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

The extent and analysis of cytokine and cytokine receptor gene polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Learning to appreciate our differences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Vaccines: correlates of vaccine-induced immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Adverse events after smallpox immunizations are associated with alterations in systemic cytokine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Genetic Predisposition for Adverse Events after Vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

The Future of Smallpox Vaccination: is MVA the key?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Cytokine expression patterns associated with systemic adverse events following smallpox immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

The immunogenetics of smallpox vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Viral commensalism in humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

MMR Vaccination and Febrile Seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

The effects of hormones on sex differences in infection: from genes to behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

The X-files in immunity: sex-based differences predispose immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Differential antibody responses to rubella virus infection in males and females

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

The contribution of HLA class I antigens in immune status following two doses of rubella vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

A measles epidemic threshold in a highly vaccinated population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Impaired antibody response to Haemophilus influenzae type b polysaccharide and low IgG2 and IgG4 concentrations in Apache children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Prevention of Haemophilus influenzae type b infections in Apache and Navajo children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Pharmacology, vaccinomics, and the second golden age of vaccinology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1659

Vaccine immunogenetics: bedside to bench to population

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2831634

Genetic basis for adverse events after smallpox vaccination

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2831634

Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2831634

Development of smallpox vaccine candidates with integrated interleukin-15 that demonstrate superior immunogenicity, efficacy, and safety in mice

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2831634

Declining population immunity to mumps among Israeli military recruits

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2831634

HLA, Gm, and Km polymorphisms and immunity to infectious diseases in South Amerinds

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2831634

Therapeutics and toxicology

2 November 2018

1 reference

12 December 2020

Vaccine safety--vaccine benefits: science and the public's perception

1 reference

12 December 2020

Sex differences in the humoral antibody response to live measles vaccine in young adults

1 reference

12 December 2020

The major histocompatibility complex haplotypes dictate and the background genes fine-tune the dominant versus the cryptic response profile of a T-cell determinant within a native antigen: relevance to disease susceptibility and vaccination

1 reference

12 December 2020

Immunology. The shape of things to come

1 reference

12 December 2020

Myopericarditis following smallpox vaccination

1 reference

12 December 2020

Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy children

1 reference

12 December 2020

Standards for child and adolescent immunization practices. National Vaccine Advisory Committee

1 reference

12 December 2020

Pros and cons of genetic association studies in hepatitis B

1 reference

12 December 2020